3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
3
Myeloid
3
Lymphoid
3
Other neoplasm
2
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
NET
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Multiple Myeloma
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Interventions
Cyclophosphamide
88
fludarabine phosphate
79
Mycophenolic Acid
64
Peripheral Blood Stem Cell Transplantation
62
Whole-Body Irradiation
51
Cyclosporine
50
Tacrolimus
49
Busulfan
45
Antilymphocyte Serum
39
Filgrastim
31
Radiotherapy
27
Methotrexate
27
fludarabine
26
Melphalan
26
Cord Blood Stem Cell Transplantation
19
Methylprednisolone
18
Etoposide
16
Sirolimus
14
Granulocyte Colony-Stimulating Factor
14
sargramostim
11
Cyclosporins
11
Therapeutics
10
Stem Cell Transplantation
10
Rituximab
10
Flow Cytometry
10
thymoglobulin
9
Alemtuzumab
9
Psychiatric Rehabilitation
8
Cytarabine
8
Transplantation
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Patient Reported Outcome Measures
×
Plasma cell
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled